Screening and prevention of venous thromboembolism in critically ill patients: A decision analysis and economic evaluation

American Journal of Respiratory and Critical Care Medicine

Volumn 184, Issue 11, 2011, Pages 1289-1298

  Sud, Sachin ^a,b   Mittmann, Nicole ^c,d,e,f   Cook, Deborah J ^b   Geerts, William ^c,g   Chan, Brian ^g   Dodek, Peter ^h,i   Gould, Michael K ^j   Guyatt, Gordon ^b   Arabi, Yaseen ^k   Fowler, Robert A ^g  

^a Trillium Health Center   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

^e Division of Clinical Pharmacology   (Canada)

^f Canada   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

^h UNIVERSITY OF BRITISH COLUMBIA   (Canada)

ⁱ ST PAUL S HOSPITAL   (Canada)

^j UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^k KING SAUD BIN ABDULAZIZ UNIVERSITY FOR HEALTH SCIENCES   (Saudi Arabia)

more..

Author keywords

Best practices; Cost effectiveness; Critical care; Ultrasound; Venous thromboembolism

Indexed keywords

HEPARIN;

ARTICLE; AUSTRALIA; BLEEDING; CANADA; CASE FINDING; COST EFFECTIVENESS ANALYSIS; CRITICALLY ILL PATIENT; DEEP VEIN THROMBOSIS; ECHOGRAPHY; HUMAN; INTENSIVE CARE UNIT; LUNG EMBOLISM; MORBIDITY; PRIORITY JOURNAL; PROBABILITY; QUALITY ADJUSTED LIFE YEAR; SENSITIVITY ANALYSIS; THROMBOCYTOPENIA; UNITED STATES;

AUSTRALIA; CANADA; COMORBIDITY; COST-BENEFIT ANALYSIS; CRITICAL ILLNESS; DECISION SUPPORT TECHNIQUES; HUMANS; MARKOV CHAINS; MONTE CARLO METHOD; QUALITY-ADJUSTED LIFE YEARS; UNITED STATES; VENOUS THROMBOEMBOLISM;

EID: 82555196046     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201106-1059OC     Document Type: Article

References (98)

1. The PROTECT Investigators. Dalteparin versus unfractionated heparin in critically ill patients. N Engl J Med 2011;364:1305-1314.
2. Cook D, Crowther M, Meade M, Rabbat C, Griffith L, Schiff D, Geerts W, Guyatt G. Deep venous thrombosis in medical-surgical critically ill patients: prevalence, incidence, and risk factors. Crit Care Med 2005;33:1565-1571. (Pubitemid 40980613)
3. Khouli H, Shapiro J, Pham VP, Arfaei A, Esan O, Jean R, Homel P. Efficacy of deep venous thrombosis prophylaxis in the medical intensive care unit. J Intensive Care Med 2006;21:352-358. (Pubitemid 44664169)
4. Patel R, Cook DJ, Meade MO, Griffith LE, Mehta G, Rocker GM, Marshall JC, Hodder R, Martin CM, Heyland DK, et al. Burden of illness in venous thromboembolism in critical care: a multicenter observational study. J Crit Care 2005;20:341-347. (Pubitemid 41727592)
5. Ibrahim EH, Iregui M, Prentice D, Sherman G, Kollef MH, Shannon W. Deep vein thrombosis during prolonged mechanical ventilation despite prophylaxis. Crit Care Med 2002;30:771-774. (Pubitemid 34297792)
6. Geerts WH, Code KI, Jay RM, Chen E, Szalai JP. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994;331:1601-1606. (Pubitemid 24372057)
7. Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR, Colwell CW. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008;133:381S-453S. (Pubitemid 351894916)
8. Attia J, Ray JG, Cook DJ, Douketis J, Ginsberg JS, Geerts WH. Deep vein thrombosis and its prevention in critically ill adults. Arch Intern Med 2001;161:1268-1279. (Pubitemid 32679576)
9. Morris RJ, Woodcock JP. Intermittent pneumatic compression or graduated compression stockings for deep vein thrombosis prophylaxis? A systematic review of direct clinical comparisons. Ann Surg 2010;251:393-396.
10. Crowther MA, Cook DJ, Griffith LE, Devereaux PJ, Rabbat CC, Clarke FJ, Hoad N, McDonald E, Meade MO, Guyatt GH, et al. Deep venous thrombosis: clinically silent in the intensive care unit. J Crit Care 2005;20:334-340. (Pubitemid 41727591)
11. Lensing AW, Prandoni P, Brandjes D, Huisman PM, Vigo M, Tomasella G, Krekt J,Wouter Ten Cate J, HuismanMV, Buller HR. Detection of deep-vein thrombosis by real-time B-mode ultrasonography. N Engl J Med 1989;320:342-345. (Pubitemid 19106869)
12. Mattos MA, Londrey GL, Leutz DW, Hodgson KJ, Ramsey DE, Barkmeier LD, Stauffer ES, Spadone DP, Sumner DS. Color-flow duplex scanning for the surveillance and diagnosis of acute deep venous thrombosis. J Vasc Surg 1992;15:366-375, discussion 75-76.
13. MonrealM,Montserrat E, Salvador R, Bechini J, Donoso L. MaCallejas J, Foz M. Real-time ultrasound for diagnosis of symptomatic venous thrombosis and for screening of patients at risk: correlation with ascending conventional venography. Angiology 1989;40:527-533. (Pubitemid 19138320)
14. Kearon C, Ginsberg JS, Hirsh J. The role of venous ultrasonography in the diagnosis of suspected deep venous thrombosis and pulmonary embolism. Ann Intern Med 1998;129:1044-1049. (Pubitemid 29005829)
15. Cook D, McMullin J, Hodder R, Heule M, Pinilla J, Dodek P, Stewart T. Prevention and diagnosis of venous thromboembolism in critically ill patients: a Canadian survey. Crit Care 2001;5:336-342. (Pubitemid 34133934)
16. Cook D, Meade M, Guyatt G, Griffith L, Granton J, Geerts W, Crowther M. Clinically important deep vein thrombosis in the intensive care unit: a survey of intensivists. Crit Care 2004;8:R145-R152.
17. Harris LM, Curl GR, Booth FV, Hassett JM Jr, Leney G, Ricotta JJ. Screening for asymptomatic deep vein thrombosis in surgical intensive care patients. J Vasc Surg 1997;26:764-769. (Pubitemid 27505612)
18. Cook D, Douketis J, Meade M, Guyatt G, Zytaruk N, Granton J, Skrobik Y, Albert M, Fowler R, Hebert P, et al. Venous thromboembolism and bleeding in critically ill patients with severe renal insufficiency receiving dalteparin thromboprophylaxis: prevalence, incidence and risk factors. Crit Care 2008;12:R32.
19. Cook DJ, Rocker G, Meade M, Guyatt G, Geerts W, Anderson D, Skrobik Y, Hebert P, Albert M, Cooper J, et al. Prophylaxis of Thromboembolism in Critical Care (PROTECT) Trial: a pilot study. J Crit Care 2005;20:364-372. (Pubitemid 41727596)
20. Goldhaber SZ, Kett DH, Cusumano CJ, Kuroki CA; for the Enoxaparin Medical Intensive Care Unit Investigators. Low molecular weight heparin versus minidose unfractionated heparin for prophylaxis against venous thromboembolism in medical intensive care unit patients: a randomized controlled trial. J Am Coll Cardiol 2000;35:325A.
21. Hirsch DR, Ingenito EP, Goldhaber SZ. Prevalence of deep venous thrombosis among patients in medical intensive care. JAMA 1995;274:335-337.
22. Kapoor M, Kupfer YY, Tessler S. Subcutaneous heparin prophylaxis significantly reduces the incidence of venous thromboembolic events in the critically ill. Crit Care Med 1999;27:A69.
23. Boddi M, Barbani F, Abbate R, Bonizzoli M, Batacchi S, Lucente E, Chiostri M, Gensini GF, Peris A. Reduction in deep vein thrombosis incidence in intensive care after a clinician education program. J Thromb Haemost 2010;8:121-128.
24. Cook D, Douketis J, Crowther MA, Anderson DR. The diagnosis of deep venous thrombosis and pulmonary embolism in medical-surgical intensive care unit patients. J Crit Care 2005;20:314-319. (Pubitemid 41727587)
25. Cox CE, Carson SS, Biddle AK. Cost-effectiveness of ultrasound in preventing femoral venous catheter-associated pulmonary embolism. Am J Respir Crit Care Med 2003;168:1481-1487. (Pubitemid 38037333)
26. Lilly CM, Cody S, Zhao H, Landry K, Baker SP, McIlwaine J, Chandler MW, Irwin RS. Hospital mortality, length of stay, and preventable complications among critically ill patients before and after tele-ICU reengineering of critical care processes. JAMA 2011;305:2175-2183.
27. Scales DC, Dainty K, Hales B, Pinto R, Fowler RA, Adhikari NK, Zwarenstein M. A multifaceted intervention for quality improvement in a network of intensive care units: a cluster randomized trial. JAMA 2011;305:363-372.
28. Sud S, Chan B, Mittman N, Geerts W, Fowler R. Diagnostic strategies for deep vein thrombosis (DVT) in critically ill patients: a cost-utility analysis. Am J Respir Crit Care Med 2009;179:A3306.
29. Sonnenberg FA, Beck JR. Markov models in medical decision making: a practical guide. Med Decis Making 1993;13:322-338. (Pubitemid 24013155)
30. Douketis JD, Foster GA, Crowther MA, Prins MH, Ginsberg JS. Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy. Arch Intern Med 2000;160:3431-3436.
31. Douketis JD, Kearon C, Bates S, Duku EK, Ginsberg JS. Risk of fatal pulmonary embolism in patients with treated venous thromboembolism. JAMA 1998;279:458-462. (Pubitemid 28082257)
32. Linkins LA, Choi PT, Douketis JD. Clinical impact of bleeding in patients taking oral anticoagulant therapy for venous thromboembolism: a meta-analysis. Ann Intern Med 2003;139:893-900.
33. Carrier M, Le Gal G, Wells PS, Rodger MA. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism. Ann Intern Med 2010;152:578-589.
34. Levine MN, Hirsh J, Gent M, Turpie AG, Weitz J, Ginsberg J, Geerts W, LeClerc J, Neemeh J, Powers P, et al. Optimal duration of oral anticoagulant therapy: a randomized trial comparing four weeks with three months of warfarin in patients with proximal deep vein thrombosis. Thromb Haemost 1995;74:606-611.
35. Hull R, Delmore T, Genton E, Hirsh J, Gent M, Sackett D, McLoughlin D, Armstrong P. Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis. N Engl J Med 1979;301:855-858. (Pubitemid 10165871)
36. Fowler RA, Pinto R, Sud S. Variability of direct medical costs among centers and countries n the prospective economic evaluation of the prophylaxis for thromboembolism in critical care trial. Crit Care Med 2007;35:A158.
37. Nanwa N, Mittmann N, Knowles S, Bucci C, Selby R, Shear N, Walker SE, Geerts W. The direct medical costs associated with suspected heparin-induced thrombocytopenia. Pharmacoeconomics 2011;29:511-520.
38. 2007 Medical Expenditure Panel Survey (Accessed November 20, 2010). Available from: http://www.meps.ahrq.gov/mepsweb.
39. Weinstein MC, Siegel JE, Gold MR, Kamlet MS, Russell LB. Recommendations of the Panel on Cost-effectiveness in Health and Medicine. JAMA 1996;276:1253-1258. (Pubitemid 26337709)
40. Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research. Am J Respir Crit Care Med 2002;165:540-550.
41. Australian Bureau of Statistics. Consumer Price Index, Australia (Accessed May 25, 2010). Available from: http://www.abs.gov.au/AUSSTATS/abs@. nsf/DetailsPage/6401.0Mar%202010?OpenDocument.
42. Consumer Price Index, health and personal care, by province (Canada) (Accessed May 25, 2010). Available from: http://www40.statcan.gc.ca/l01/cst01/ ECON161A-eng.htm.
43. Bureau of Labour and Statistics. Consumer Price Index (United States) (Accessed May 25, 2010). Available from: http://www.bls.gov/cpi/.
44. Reserve bank of Australia (Accessed May 25, 2010). Available from: http://www.rba.gov.au/.
45. Bank of Canada. Rates and Statistics (Accessed May 25, 2010). Available from: http://www.bankofcanada.ca/en/rates/exchange.html.
46. Campbell AJ, Cook JA, Adey G, Cuthbertson BH. Predicting death and readmission after intensive care discharge. Br J Anaesth 2008;100:656-662. (Pubitemid 351774373)
47. Williams TA, Dobb GJ, Finn JC, Knuiman MW, Geelhoed E, Lee KY, Webb SA. Determinants of long-term survival after intensive care. Crit Care Med 2008;36:1523-1530. (Pubitemid 351620661)
48. Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 2010;304:1787-1794.
49. Quartin AA, Schein RM, Kett DH, Peduzzi PN. Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group. JAMA 1997;277:1058-1063.
50. Bergqvist D, Jendteg S, Johansen L, Persson U, Odegaard K. Cost of long-term complications of deep venous thrombosis of the lower extremities: an analysis of a defined patient population in Sweden. Ann Intern Med 1997;126:454-457. (Pubitemid 27114474)
51. Gould MK, Dembitzer AD, Sanders GD, Garber AM. Low-molecular-weight heparins compared with unfractionated heparin for treatment of acute deep venous thrombosis. A cost-effectiveness analysis. Ann Intern Med 1999;130:789-799. (Pubitemid 29231147)
52. Hamel MB, Phillips RS, Davis RB, Teno J, Connors AF, Desbiens N, Lynn J, Dawson NV, Fulkerson W, Tsevat J. Outcomes and cost-effectiveness of ventilator support and aggressive care for patients with acute respiratory failure due to pneumonia or acute respiratory distress syndrome. Am J Med 2000;109:614-620.
53. Angus DC, Musthafa AA, Clermont G, Griffin MF, Linde-Zwirble WT, Dremsizov TT, Pinsky MR. Quality-adjusted survival in the first year after the acute respiratory distress syndrome. Am J Respir Crit Care Med 2001;163:1389-1394. (Pubitemid 32506604)
54. Cuthbertson BH, Roughton S, Jenkinson D, Maclennan G, Vale L. Quality of life in the five years after intensive care: a cohort study. Crit Care 2010;14:R6.
55. Hung MC, Yan YH, Fan PS, Lin MS, Chen CR, Kuo LC, Yu CJ, Yao G, Hsieh CL, Wang JD. Measurement of quality of life using EQ-5D in patients on prolonged mechanical ventilation: comparison of patients, family caregivers, and nurses. Qual Life Res 2010;19:721-727.
56. World Heath Organziation. CHOosing Interventions that are Cost Effective (WHO-CHOICE) (Accessed November 28, 2010). Available from: http://www.who.int/ choice/costs/CER-levels/en/index.html.
57. Cook D, Laporta D, Skrobik Y, Peters S, Sharpe M, Murphy P, Chin D, Crowther M. Prevention of venous thromboembolism in critically ill surgery patients: a cross-sectional study. J Crit Care 2001;16:161-166. (Pubitemid 34106651)
58. Lacherade JC, Cook D, Heyland D, Chrusch C, Brochard L, Brun- Buisson C. Prevention of venous thromboembolism in critically ill medical patients: a Franco-Canadian cross-sectional study. J Crit Care 2003;18:228-237. (Pubitemid 38036904)
59. Robertson MS, Nichol AD, Higgins AM, Bailey MJ, Presneill JJ, Cooper DJ, Webb SA, McArthur C, MacIsaac CM. Venous thromboembolism prophylaxis in the critically ill: a point prevalence survey of current practice in Australian and New Zealand intensive care units. Crit Care Resusc 2010;12:9-15.
60. Angus DC, Linde-Zwirble WT, Clermont G, Ball DE, Basson BR, Ely EW, Laterre PF, Vincent JL, Bernard G, van Hout B. Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis. Crit Care Med 2003;31:1-11. (Pubitemid 36151142)
61. Cooke CR, Kahn JM, Watkins TR, Hudson LD, Rubenfeld GD. Cost-effectiveness of implementing low-tidal volume ventilation in patients with acute lung injury. Chest 2009;136:79-88.
62. Huang DT, Clermont G, Dremsizov TT, Angus DC. Implementation of early goal-directed therapy for severe sepsis and septic shock: a decision analysis. Crit Care Med 2007;35:2090-2100. (Pubitemid 47326446)
63. Fraisse F, Holzapfel L, Couland JM, Simonneau G, Bedock B, FeisselM, Herbecq P, Pordes R, Poussel JF, Roux L. Nadroparin in the prevention of deep vein thrombosis in acute decompensated COPD. The Association of Non-University Affiliated Intensive Care Specialist Physicians of France. Am J Respir Crit Care Med 2000;161:1109-1114.
64. Marik PE, Andrews L, Maini B. The incidence of deep venous thrombosis in ICU patients. Chest 1997;111:661-664. (Pubitemid 27132943)
65. Rozycki GS, Tchorz KM, Riehle KJ, Hattaway A, Naidu DK. A prospective study of a focused, surgeon-performed ultrasound examination for the detection of occult common femoral vein thrombosis in critically ill patients. Arch Surg 2004;139:275-280. (Pubitemid 38282668)
66. De A, Roy P, Garg VK, Pandey NK. Low-molecular-weight heparin and unfractionated heparin in prophylaxis against deep vein thrombosis in critically ill patients undergoing major surgery. Blood Coagul Fibrinolysis 2010;21:57-61.
67. Cook D, Attia J, Weaver B, McDonald E, Meade M, Crowther M. Venous thromboembolic disease: an observational study in medical-surgical intensive care unit patients. J Crit Care 2000;15:127-132.
68. Geerts WH, Jay RM, Code KI, Chen E, Szalai JP, Saibil EA, Hamilton PA. A comparison of low-dose heparin with low-molecular-weight heparin as prophylaxis against venous thromboembolism after major trauma. N Engl J Med 1996;335:701-707. (Pubitemid 26287356)
69. Borer DS, Starr AJ, Reinert CM, Rao AV, Weatherall P, Thompson D, Champine J, Jones AL. The effect of screening for deep vein thrombosis on the prevalence of pulmonary embolism in patients with fractures of the pelvis or acetabulum: a review of 973 patients. J Orthop Trauma 2005;19:92-95. (Pubitemid 40340216)
70. Cipolle MD, Wojcik R, Seislove E, Wasser TE, Pasquale MD. The role of surveillance duplex scanning in preventing venous thromboembolism in trauma patients. J Trauma 2002;52:453-462. (Pubitemid 34230076)
71. Robinson KS, Anderson DR, Gross M, Petrie D, Leighton R, Stanish W, Alexander D, Mitchell M, Flemming B, Gent M. Ultrasonographic screening before hospital discharge for deep venous thrombosis after arthroplasty: the post-arthroplasty screening study: a randomized, controlled trial. Ann Intern Med 1997;127:439-445. (Pubitemid 27400906)
72. Kakkar VV, Howe CT, Flanc C, Clarke MB. Natural history of post-operative deep-vein thrombosis. Lancet 1969;2:230-232.
73. Kearon C. Natural history of venous thromboembolism. Circulation 2003;107:I22-I30. (Pubitemid 41289268)
74. Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ. Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost 2005;93:76-79. (Pubitemid 40124258)
75. Reis SE, Polak JF, Hirsch DR, Cohn LH, Creager MA, Donovan BC, Goldhaber SZ. Frequency of deep venous thrombosis in asymptomatic patients with coronary artery bypass grafts. Am Heart J 1991;122:478-482.
76. Furlan JC, Fehlings MG. Role of screening tests for deep venous thrombosis in asymptomatic adults with acute spinal cord injury: an evidence-based analysis. Spine 2007;32:1908-1916. (Pubitemid 47356575)
77. Montgomery KD, Potter HG, Helfet DL. The detection and management of proximal deep venous thrombosis in patients with acute acetabular fractures: a follow-up report. J Orthop Trauma 1997;11:330-336. (Pubitemid 127789821)
78. Napolitano LM, Garlapati VS, Heard SO, Silva WE, Cutler BS, O'Neill AM, Anderson FA Jr, Wheeler HB. Asymptomatic deep venous thrombosis in the trauma patient: is an aggressive screening protocol justified? J Trauma 1995;39:651-657, discussion 7-9.
79. Quinlan DJ, Eikelboom JW, Dahl OE, Eriksson BI, Sidhu PS, Hirsh J. Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery. J Thromb Haemost 2007;5:1438-1443. (Pubitemid 46965372)
80. Eriksson BI, Lassen MR. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med 2003;163:1337-1342. (Pubitemid 36676199)
81. Cook DJ, Fuller HD, Guyatt GH, Marshall JC, Leasa D, Hall R, Winton TL, Rutledge F, Todd TJ, Roy P, et al. Risk factors for gastrointestinal bleeding in critically ill patients. Canadian Critical Care Trials Group. N Engl J Med 1994;330:377-381. (Pubitemid 24045653)
82. Cook DJ, Griffith LE, Walter SD, Guyatt GH, Meade MO, Heyland DK, Kirby A, Tryba M. The attributable mortality and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients. Crit Care 2001;5:368-375. (Pubitemid 34130340)
83. Barritt DW, Jordan SC. Anticoagulant drugs in the treatment of pulmonary embolism: a controlled trial. Lancet 1960;1:1309-1312.
84. Meignan M, Rosso J, Gauthier H, Brunengo F, Claudel S, Sagnard L, d'Azemar P, Simonneau G, Charbonnier B. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. Arch Intern Med 2000;160:159-164. (Pubitemid 30054334)
85. Cade JF. High risk of the critically ill for venous thromboembolism. Crit Care Med 1982;10:448-450.
86. Moser KM, LeMoine JR, Nachtwey FJ, Spragg RG. Deep venous thrombosis and pulmonary embolism. Frequency in a respiratory intensive care unit. JAMA 1981;246:1422-1424. (Pubitemid 11000091)
87. Elias A, Le Corff G, Bouvier JL, Benichou M, Serradimigni A. Value of real time B mode ultrasound imaging in the diagnosis of deep vein thrombosis of the lower limbs. Int Angiol 1987;6:175-182.
88. Perrier A. Noninvasive diagnosis of pulmonary embolism. Haematologica 1997;82:328-331. (Pubitemid 28023310)
89. Goodacre S, Sampson F, Thomas S, van Beek E, Sutton A. Systematic review and meta-analysis of the diagnostic accuracy of ultrasonography for deep vein thrombosis. BMC Med Imaging 2005;5:6.
90. Bump GM, Dandu M, Kaufman SR, Shojania KG, Flanders SA. How complete is the evidence for thromboembolism prophylaxis in general medicine patients? A meta-analysis of randomized controlled trials. J Hosp Med 2009;4:289-297.
91. Dentali F, Douketis JD, Gianni M, Lim W, Crowther MA. Meta-analysis: anticoagulant prophylaxis to prevent symptomatic venous thromboembolism in hospitalized medical patients. Ann Intern Med 2007;146:278-288. (Pubitemid 351650614)
92. Sjalander A, Jansson JH, Bergqvist D, Eriksson H, Carlberg B, Svensson P. Efficacy and safety of anticoagulant prophylaxis to prevent venous thromboembolism in acutely ill medical inpatients: a meta-analysis. J Intern Med 2008;263:52-60. (Pubitemid 350243550)
93. Arnold DM, Donahoe L, Clarke FJ, Tkaczyk AJ, Heels-Ansdell D, Zytaruk N, Cook R, Webert KE, McDonald E, Cook DJ. Bleeding during critical illness: a prospective cohort study using a new measurement tool. Clin Invest Med 2007;30:E93-E102. (Pubitemid 47535698)
94. Brown RB, Klar J, Teres D, Lemeshow S, Sands M. Prospective study of clinical bleeding in intensive care unit patients. Crit Care Med 1988;16:1171-1176. (Pubitemid 19017847)
95. Vincent JL, Baron JF, Reinhart K, Gattinoni L, Thijs L, Webb A, Meier-Hellmann A, Nollet G, Peres-Bota D. Anemia and blood transfusion in critically ill patients. JAMA 2002;288:1499-1507.
96. Kahn JM, Goss CH, Heagerty PJ, Kramer AA, O'Brien CR, Rubenfeld GD. Hospital volume and the outcomes of mechanical ventilation. N Engl J Med 2006;355:41-50.
97. Nand S, Wong W, Yuen B, Yetter A, Schmulbach E, Gross Fisher S. Heparin-induced thrombocytopenia with thrombosis: incidence, analysis of risk factors, and clinical outcomes in 108 consecutive patients treated at a single institution. Am J Hematol 1997;56:12-16. (Pubitemid 27398052)
98. Kahn JM, Benson NM, Appleby D, Carson SS, Iwashyna TJ. Long-term acute care hospital utilization after critical illness. JAMA 2010;303:2253-2259.